Skip to main content
Main Menu
  • Capabilities
    Back
    Capabilities
    • Assembly
    • Catheter Design
    • High Purity Specialty Closures
      Back
      High Purity Specialty Closures
      • Closure Assemblies
      • Liners
    • COVID-19 Rapid Manufacturing Capabilities
    • Custom Compounding
    • Custom Filtration
    • Medical Extrusion
    • Medical Molding
    • Prototyping and Tooling
    • Product Co-Development
  • Materials
    Back
    Materials
    • Fluoropolymers
      Back
      Fluoropolymers
      • Basics 101: Fluoropolymers
    • Other Materials
    • Silicone
      Back
      Silicone
      • Basics of Silicone:101
    • Thermoplastics
      Back
      Thermoplastics
      • Basics 101: Thermoplastics
      • PEEK page
  • Markets
    Back
    Markets
    • Cardiology
    • Diabetic Care
    • Drug Delivery
    • Nephrology
    • Ophthalmology
    • Other Medical Markets
    • Surgery
  • Resources
    Back
    Resources
    • Schedule a Lunch and Learn
    • Technical Data and Literature
    • White Papers
      Back
      White Papers
      • Effect of Sterilization on the Mechanical Properties
      • Extruded Silicone Tubing with Optimized Precision for medical device manufacturers
      • Flow Rate Stability of Medical Peristaltic Pump Tubing Materials
      • Liquid Silicone Rubber Injection Molding
      • Low Coefficient of Friction Materials: Tygon® LCF Offers the Ideal Combination
      • The Impact of Gamma and Autoclave Sterilization on Silicone Tubing
      • Two-Shot Silicone-Thermoplastic Medical Molding
    • Quality and Regulatory
      Back
      Quality and Regulatory
      • ISO Certifications
      • Medical Product Disclaimer
    • FAQs
    • Videos
  • About Us
    Back
    About Us
    • Events
    • Blog
    • News
    • Case Study
  • Contact Us
world SAINT-GOBAIN
Logo Saint-Gobain Medical
  • Capabilities
    • Assembly
    • Catheter Design
    • High Purity Specialty Closures
      • Closure Assemblies
      • Liners
    • COVID-19 Rapid Manufacturing Capabilities
    • Custom Compounding
    • Custom Filtration
    • Medical Extrusion
    • Medical Molding
    • Prototyping and Tooling
    • Product Co-Development
  • Materials
    • Fluoropolymers
      • Basics 101: Fluoropolymers
    • Other Materials
    • Silicone
      • Basics of Silicone:101
    • Thermoplastics
      • Basics 101: Thermoplastics
      • PEEK page
  • Markets
    • Cardiology
    • Diabetic Care
    • Drug Delivery
    • Nephrology
    • Ophthalmology
    • Other Medical Markets
    • Surgery
  • Resources
    • Schedule a Lunch and Learn
    • Technical Data and Literature
    • White Papers
      • Extruded Silicone Tubing with Optimized Precision for medical device manufacturers
      • Two-Shot Silicone-Thermoplastic Medical Molding
      • The Impact of Gamma and Autoclave Sterilization on Silicone Tubing
      • Low Coefficient of Friction Materials: Tygon® LCF Offers the Ideal Combination
      • Liquid Silicone Rubber Injection Molding
      • Flow Rate Stability of Medical Peristaltic Pump Tubing Materials
      • Effect of Sterilization on the Mechanical Properties
    • Quality and Regulatory
      • Medical Product Disclaimer
      • ISO Certifications
    • FAQs
    • Videos
  • About Us
    • Events
    • Blog
    • News
    • Case Study
  • Contact Us
COVID-19 Rapid Manufacturing Capabilities – LEARN MORE

You are here

  1. Home
  2. About Us
  3. News
  4. Michigan Flooding / Saint-Gobain Beaverton Facility

Michigan Flooding / Saint-Gobain Beaverton Facility

May 22nd, 2020

The Mid-Michigan region of the United States is currently in the middle of historic flooding, with multiple dam failures throughout the region. The area has been placed under a State of Emergency.

Saint-Gobain Life Sciences’ Beaverton manufacturing facility is located within this region and our primary concerns are the safety of our employees and our customers’ ability to get deliveries without disruptions. Therefore, we would like to provide you with an update on our site’s current status and the actions we are taking to support employees impacted by the flooding and monitor the situation to avoid disruptions to operations.

Saint-Gobain Beaverton Manufacturing Operations / Business Continuity

Currently, the Saint-Gobain Beaverton site is up and running, with no flooding or damage. Site operations continue and customer orders have not been impacted.

Employee Safety and Support

While flooding did not occur at our plant, it has affected about 12% of our employees who have been evacuated or experienced damage to their homes or property.  Our Saint-Gobain and local Human Resources teams are working closely together to provide support to these employees. 

Supply Chain and Logistics

We are closely monitoring damage to infrastructure in nearby communities, including bridges and roads, to identify any potential impact to our Supply Chain and Logistics. Our Beaverton team is working with freight companies by providing directions, maps, and alternate routes to access the site. At this time, we do not see an impact to our incoming deliveries or outgoing shipments, but the situation continues to evolve.

We remain committed to honoring our commitments to our customers. We will continue to monitor the situation as it changes and keep you informed if we identify any developments which may impact our operations.

About Saint-Gobain

Saint-Gobain designs, manufactures and distributes materials and solutions which are key ingredients in the wellbeing of each of us and the future of all. They can be found everywhere in our living places and our daily life: in buildings, transportation, infrastructure and in so many industrial applications.

 

Saint-Gobain Performance Plastics' group of businesses gather solutions to save energy, provide protection, improve comfort and sustain the environment for a variety of markets.

MENU

Capabilities
Materials
Markets
Resources
FAQs
About Us
Contact Us
Schedule a Lunch and Learn
Legal
CATSCA

 

 

 

FOLLOW US

 

 CONTACT US

Saint-Gobain’s medical products are distributed exclusively to medical device manufacturers for use in the manufacture, assembly or distribution of their medical devices. Saint-Gobain cannot authorize the sale of its medical products directly to device user facilities (e.g. hospitals, surgery centers, nursing home, clinics, etc.), nor directly to end users (e.g. patients, patients’ caregiver, prescribing physician, nurse, pharmacist, etc.), including distributors serving device user facilities and end users directly. In accordance with every jurisdiction globally, Saint-Gobain’s customers are responsible for determining that any medical device they manufacture and market that incorporates a Saint-Gobain’s medical product, is compliant with each country-specific medical device regulations and has received proper country-specific clearance, certification or registration authorizing the sale of this medical device.


Saint-Gobain’s medical products offer covers:
- Medical Components [21 CFR 820.3(c)], intended for processing or use in the manufacture or assembly of medical devices before the finished medical device is packaged/labeled; Medical Components are intended to be included as part of the finished, packaged, and labeled device [21CFR820.3(c)].
- Finished Devices [21CFR820.3(l)] made on behalf of medical device manufacturers [21 CFR 807.20(a)(2)] under contract-manufacturing agreement. In accordance with the United States’ jurisdiction, Saint-Gobain complies with the FDA’s requirements for contract manufacturers of finished devices.

© Copyright Saint-Gobain 2019. All rights reserved.